Pharma News

NEW YORK (Reuters Health) Sep 02 - Antidepressants rarely trigger suicidal thoughts or behaviors, suggests a large study of patients in European psychiatric hospitals.

But some experts question the data in the study, saying suicidal thoughts or behaviors were probably written off as part of the patient's illness, or that some cases of patients feeling or acting suicidal might have been missed altogether.

The Pharmacy Council of India is a statutory body constituted under section 3 of the Pharmacy Act, 1948.  The Council is empowered to prescribe minimum standard of education and to approve courses of study and examinations for the purpose of qualifying for registration as a pharmacist under section 10 & 12 of said Act.

The U.S. Food and Drug Administration is warning consumers not to take TimeOut Capsules because it contains an active drug ingredient that can dangerously lower blood pressure. The product is marketed as a dietary supplement for sexual enhancement.

Researchers have found murine leukemia viruses (MLV) related gene sequences in blood samples collected from patients diagnosed with chronic fatigue syndrome (CFS) and some healthy blood donors, according to a study published online today by the scientific journal Proceedings of the National Academy of Sciences (PNAS).

There is a direct and linear association between plasma beta-amyloid (Aβ) levels and multiple aspects of cognitive decline over time, including cognitive changes that constitute conversion to Alzheimer's disease, according to new findings from a population-based, ethnically diverse longitudinal sample of older adults.

Despite denials by the Government and stern measures including the introduction of special barcode, the supply of sub-standard drugs for the Central Government Health Scheme (CGHS) and pilferage of drugs continue in many places, it is learnt.

Prophylactic gentamicin-collagen sponges do not appear to significantly decrease infection rate compared with no intervention in patients undergoing colorectal surgery, according to the findings of a large randomized phase 3 trial.

Bayer Schering Pharma AG, Berlin, Germany, announced that the Food and Drug Administration (FDA) has accepted for filing a New Drug Application to the US for gadobutrol injection, a gadolinium-based contrast agent for magnetic resonance imaging (MRI).

[adsense:336x280:8701650588]

In patients with mild Alzheimer's disease (AD), deep brain stimulation (DBS) modulates specific brain circuits important in memory and is safe, according to results of the first phase 1 study of DBS for AD, published online July 30 in the Annals of Neurology.